CD68 and colitis: During the course of DSS-induced colitis, WT and CD68–mEPRAP transgenic mice had no significant difference in mortality or body weight loss (S9A and S9B Fig); however, CD68–mEPRAP transgenic mice showed markedly reduced colon shortening (Fig 5A and 5B).